SUPN
Supernus Pharmaceuticals Inc
2 of the 83 super-investors we track hold SUPN, worth a combined $71M per their latest 13F filings. The largest position: Third Avenue Management at 1.1% of their portfolio. No cohort buying or selling was filed on the name this quarter. Conviction score: 26 of 100 (how strongly the cohort backs it) — ranked #498 of 742 stocks.
Why super-investors own SUPN
SUPN is held by 2 super-investors in our cohort, with a combined position value of $71M. The highest-conviction owner is Third Avenue Management at 1.1% of their portfolio.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2016Q4 → 2026Q2How many of the cohort members held this stock each quarter.
Owners (2) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Joel Greenblatt | <0.1% | 36q | $64M | 1,373,982 |
| 2 | Third Avenue Management | 1.1% | 17q | $7M | 152,724 |
Owners of SUPN also hold
Congress is trading SUPN
Congress tracker →- Gilbert Cisnerosbought$1,001 - $15,000 · 2026-03-03
- Gilbert Cisnerosbought$1,001 - $15,000 · 2025-12-11
- Gilbert Cisnerossold$1,001 - $15,000 · 2025-10-09
- Gilbert Cisnerosbought$1,001 - $15,000 · 2025-03-24
- Josh Gottheimersold$1,001 - $15,000 · 2022-12-23
- Gilbert Cisnerosbought$1,001 - $15,000 · 2020-11-13
STOCK Act periodic transaction reports; amounts are disclosed ranges. Who files late →
Long US equity 13F-HR filings only. CUSIP 868459108. Not investment advice.